Evidence map›Paper›PMID 35953453›Full record

ArticleAdvanced healthcare materials2022

The Modular µSiM Reconfigured: Integration of Microfluidic Capabilities to Study In Vitro Barrier Tissue Models under Flow.

Mehran Mansouri, Adeel Ahmed, S Danial Ahmad, Molly C McCloskey, Indranil M Joshi, Thomas R Gaborski, Richard E Waugh, James L McGrath, Steven W Day, Vinay V Abhyankar

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Modeling Brain Vasculature Immune Interactions In Vitro.Cold Spring Harbor perspectives in medicine · 2023
    Review
  12. Review
  13. Article
  14. Review
  15. Microengineering 3D Collagen Hydrogels with Long-Range Fiber Alignment.Journal of visualized experiments : JoVE · 2022
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mehran MansouriDepartment of Biomedical Engineering, Rochester Institute of Technology, Rochester, NY, 14623, USA.ORCID 0000-0002-2949-1857
Adeel AhmedDepartment of Biomedical Engineering, Rochester Institute of Technology, Rochester, NY, 14623, USA.
S Danial AhmadDepartment of Biomedical Engineering, University of Rochester, Rochester, NY, 14627, USA.
Molly C McCloskeyDepartment of Biomedical Engineering, University of Rochester, Rochester, NY, 14627, USA.
Indranil M JoshiDepartment of Biomedical Engineering, Rochester Institute of Technology, Rochester, NY, 14623, USA.
Thomas R GaborskiDepartment of Biomedical Engineering, Rochester Institute of Technology, Rochester, NY, 14623, USA.
Richard E WaughDepartment of Biomedical Engineering, University of Rochester, Rochester, NY, 14627, USA.
James L McGrathDepartment of Biomedical Engineering, University of Rochester, Rochester, NY, 14627, USA.
Steven W DayDepartment of Biomedical Engineering, Rochester Institute of Technology, Rochester, NY, 14623, USA.
Vinay V AbhyankarDepartment of Biomedical Engineering, Rochester Institute of Technology, Rochester, NY, 14623, USA.ORCID 0000-0002-8462-3920

Funding

VISUAL INDICES OF NEUROTOXICITYP30ES001247 · NIEHS · UNIVERSITY OF ROCHESTER · PI Martha Susiarjo · 1985 to 2026
$42.8M
A microphysiological system of tendon inflammation and fibrosis for drug screening and efficacy testingUH3TR003281 · NCATS · UNIVERSITY OF ROCHESTER · PI AWAD, HANI A, MCGRATH, JAMES L · 2022 to 2024
$2.2M
Commercializing the μSIM: A Modular Platform for the Development and Analysis of Barrier Tissue ModelsR44GM137651 · NIGMS · SIMPORE, INC. · PI ROUSSIE, JAMES ANDREW · 2022 to 2023
$1.7M
A microphysiological system of tendon inflammation and fibrosis for drug screening and efficacy testing: MPS Database EngagementUG3TR003281 · NCATS · UNIVERSITY OF ROCHESTER · PI AWAD, HANI A, MCGRATH, JAMES L · 2020 to 2021
$1.6M
The µSiM-hNVU - a human BBB platform for the study of brain injury mechanisms during systemic infectionR61HL154249 · NHLBI · UNIVERSITY OF ROCHESTER · PI ENGELHARDT, BRITTA, GABORSKI, THOMAS R · 2020 to 2021
$1.2M
Commercializing the µSIM: A Modular Platform for the Development and Analysis of Barrier Tissue ModelsR43GM137651 · NIGMS · SIMPORE, INC. · PI ROUSSIE, JAMES ANDREW · 2020 to 2020
$235k
NCATS NIH HHS UG3 TR003281NCATS NIH HHS UH3 TR003281NHLBI NIH HHS R61 HL154249NIEHS NIH HHS P30 ES001247NIGMS NIH HHS R43 GM137651NIGMS NIH HHS R44 GM137651
6 · The paper itself

Abstract

Microfluidic tissue barrier models have emerged to address the lack of physiological fluid flow in conventional "open-well" Transwell-like devices. However, microfluidic techniques have not achieved widespread usage in bioscience laboratories because they are not fully compatible with traditional experimental protocols. To advance barrier tissue research, there is a need for a platform that combines the key advantages of both conventional open-well and microfluidic systems. Here, a plug-and-play flow module is developed to introduce on-demand microfluidic flow capabilities to an open-well device that features a nanoporous membrane and live-cell imaging capabilities. The magnetic latching assembly of this design enables bi-directional reconfiguration and allows users to conduct an experiment in an open-well format with established protocols and then add or remove microfluidic capabilities as desired. This work also provides an experimentally-validated flow model to select flow conditions based on the experimental needs. As a proof-of-concept, flow-induced alignment of endothelial cells and the expression of shear-sensitive gene targets are demonstrated, and the different phases of neutrophil transmigration across a chemically stimulated endothelial monolayer under flow conditions are visualized. With these experimental capabilities, it is anticipated that both engineering and bioscience laboratories will adopt this reconfigurable design due to the compatibility with standard open-well protocols.

Indexed as

Microfluidic Analytical TechniquesMicrofluidicsEndothelial Cellsmicrofluidicsmicrophysiological systemsmodular designsphysiological flowstissue chipsvascular barriers

Identifiers

PMID35953453
PMCPMC9798530

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.